2025/0109,172 | METHODS OF DETECTION AND REMOVAL OF RHABDOVIRUSES FROM CELL LINES | May 15, 24 | Apr 03, 25 | Not available |
2025/0109,226 | NATIVE CELL MEMBRANE NANOPARTICLES | Feb 20, 24 | Apr 03, 25 | Not available |
2025/0092,118 | HIGHLY PURIFIED INSOLUBLE COLLAGEN FIBERS FOR MEDICAL APPLICATIONS | Sep 10, 24 | Mar 20, 25 | Shu-Tung and Alice Li Foundation Inc. |
2025/0084,122 | VOLUMETRIC ABSORPTIVE MICROSAMPLING DEVICES AND METHODS OF USING THE SAME | Jan 06, 23 | Mar 13, 25 | Sangui Bio Pty Ltd; The University of Sydney; |
2025/0043,082 | CROSSLINKING AGENTS AND MEDICAL HYDROGELS FORMED THEREFROM | Jul 23, 24 | Feb 06, 25 | Boston Scientific Scimed Inc. |
2025/0026,783 | Intermittent Percolation Washing | Oct 16, 22 | Jan 23, 25 | Not available |
2025/0000,121 | METHOD FOR REDUCING THE BITTERNESS OF A LEGUMINOUS PROTEIN | Sep 21, 22 | Jan 02, 25 | Not available |
2024/0425,621 | Terpolymers for Lipid Nanodisc Formation | Dec 14, 22 | Dec 26, 24 | Stellenbosch University |
2024/0425,610 | PREVENTION OF DISULFIDE BOND REDUCTION DURING RECOMBINANT PRODUCTION OF POLYPEPTIDES | Sep 04, 24 | Dec 26, 24 | Genentech, Inc. |
2024/0408,513 | SEPARATION SYSTEM AND METHOD FOR SEPARATING AND PURIFYING A TARGET COMPONENT | Oct 13, 22 | Dec 12, 24 | SARTORIUS STEDIM BIOTECH GMBH |
2024/0400,611 | A PROCESS OF FLOCCULATION TO PURIFY CRUDE FERMENTATION BROTH | Sep 15, 22 | Dec 05, 24 | BIOCON BIOLOGICS LIMITED |
2024/0390,869 | METHODS OF CONTROLLING THE LEVEL OF DISSOLVED OXYGEN (DO) IN A SOLUTION COMPRISING A RECOMBINANT PROTEIN IN A STORAGE CONTAINER | Sep 20, 22 | Nov 28, 24 | Bristol Myers Squibb Company |
2024/0393,354 | LIPOPROTEIN ANALYSIS BY DIFFERENTIAL CHARGED-PARTICLE MOBILITY | Aug 01, 24 | Nov 28, 24 | Not available |
2024/0392,017 | HIGH CONCENTRATION ANTIBODY-CONTAINING LIQUID FORMULATION | Aug 01, 24 | Nov 28, 24 | Not available |
2024/0382,978 | METHOD OF CONCENTRATING A PLANT-BASED PROTEIN SUSPENSION | Aug 31, 22 | Nov 21, 24 | Alfa Laval Corporate AB |
2024/0385,113 | METHOD OF DETERMINING A FUTURE COLOR VALUE OR CORRESPONDING PROPERTY AND ARRANGEMENT THEREFOR | Sep 02, 22 | Nov 21, 24 | Boehringer Ingelheim International GmbH |
2024/0384,243 | VIRAL CLEARANCE BY LOW PH HOLD | Jul 19, 24 | Nov 21, 24 | Regeneron Pharmaceuticals, Inc. |
2024/0376,509 | Methods of Controlling Cleavage of Formylglycine-Containing Polypeptides | May 25, 22 | Nov 14, 24 | Not available |
2024/0376,219 | HIGH CONCENTRATION ANTIBODY-CONTAINING LIQUID FORMULATION | Jul 23, 24 | Nov 14, 24 | Not available |
2024/0365,841 | PURIFICATION OF TOBACCO-DERIVED PROTEIN COMPOSITIONS | Jul 16, 24 | Nov 07, 24 | Not available |